Hemodialysis with cuprophane membrane modulates interleukin-2 receptor expression

Area of Science:

• Immunology
• Nephrology
• Biomaterials Science

Background:

• Chronic dialysis patients exhibit immune deficiencies.
• Lymphocyte interleukin-2 (IL-2) receptor expression is crucial for cellular immune response.
• Dialysis membrane biocompatibility may affect immune function.

Purpose of the Study:

• To investigate the influence of dialysis membranes on lymphocyte IL-2 receptor expression.
• To determine if cuprophane and polymethylmethacrylate (PMMA) membranes differentially affect immune response.
• To explore the role of blood-membrane interactions in immune deficiency.

Main Methods:

• Cross-over study involving eight chronic hemodialysis patients.
• Comparison of cuprophane and PMMA dialysis membranes.
• Measurement of IL-2 receptor subunits (alpha and beta) on peripheral blood mononuclear cells (PBMC).
• In vitro experiments with PBMC, cuprophane membranes, and C5a anaphylatoxin.

Main Results:

• Cuprophane membrane dialysis increased baseline IL-2 receptor subunit expression (IL2R alpha and IL-2R beta) on PBMC.
• Phytohemagglutinin (PHA) stimulation showed decreased high-affinity IL-2 receptor expression after cuprophane dialysis.
• These effects were reversed with PMMA membranes, which showed minimal complement activation.
• In vitro studies confirmed cuprophane membrane contact and C5a increased IL-2 receptor subunit expression.

Conclusions:

• Dialysis membranes, particularly cuprophane, significantly interact with lymphocytes.
• The observed changes in IL-2 receptor expression may contribute to immune deficiency in dialysis patients.
• PMMA membranes appear more biocompatible, preserving lymphocyte function during dialysis.